Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Not applicableUnknownNCT03668418
What this trial is testing

Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos

Who this might be right for
Liver CancerPancreatic CancerGastric Cancer+4 more
University of Pisa 120
Not applicableStudy completedNCT02330913
What this trial is testing

Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy

Who this might be right for
Gastric Cancer
Keimyung University Dongsan Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06067438
What this trial is testing

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Who this might be right for
Atrial FibrillationEsophageal Carcinoma
OHSU Knight Cancer Institute 90
Testing effectiveness (Phase 2)Ended earlyNCT00618917
What this trial is testing

MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
EsophagealToxicity
Joel Greenberger 18
Early research (Phase 1)Study completedNCT02876510
What this trial is testing

ACTolog in Patients With Solid Cancers

Who this might be right for
CancerSolid Tumor
Immatics US, Inc. 38
Not applicableNot Yet RecruitingNCT07605312
What this trial is testing

AI-Based Risk Prediction Model for Upper Digestive Tract Cancer

Who this might be right for
Gastric Cancer (GC)Premalignant LesionGastric Intestinal Metaplasia+3 more
National Taiwan University Hospital 10,000
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Testing effectiveness (Phase 2)UnknownNCT03910634
What this trial is testing

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

Who this might be right for
Esophageal CancerRadiotherapy Side Effect
Sun Yat-sen University 264
Not applicableEnded earlyNCT03377660
What this trial is testing

Resection of the Esophagus and Subsequent Weight Loss

Who this might be right for
Esophageal CancerWeight GainEating Behavior+1 more
Imperial College London 30
Not applicableWithdrawnNCT05041335
What this trial is testing

Wet Heparinized Suction for Abdominal Cancer

Who this might be right for
Cancer of PancreasCancer of StomachCancer of Esophagus+2 more
H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT01216813
What this trial is testing

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 33
Testing effectiveness (Phase 2)Ended earlyNCT04467515
What this trial is testing

Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer

Who this might be right for
Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
Precirix 13
Not applicableUnknownNCT05050760
What this trial is testing

DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer

Who this might be right for
ESCC
Xijing Hospital 55
Large-scale testing (Phase 3)Looking for participantsNCT04821778
What this trial is testing

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Who this might be right for
Esophagus CancerEsophagogastric Junction CancerChemoradiation+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,000
Not applicableStudy completedNCT03816748
What this trial is testing

The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients

Who this might be right for
Esophageal Cancer
National Taiwan University Hospital 69
Not applicableWithdrawnNCT00372450
What this trial is testing

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastrointestinal Complications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableNot Yet RecruitingNCT07658313
What this trial is testing

Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery

Who this might be right for
Gastrointestinal NeoplasmsPancreatic NeoplasmsLiver Neoplasm+6 more
Ludwig Boltzmann Institute for Digital Health and Prevention 30
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Not applicableStudy completedNCT02850991
What this trial is testing

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Peking University Cancer Hospital & Institute 167
Next Page